Search results
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 3 days agoModerna became a household name thanks to the success of its mRNA vaccine against COVID-19. Along...
Flagship taps startup to hunt for obesity drugs that might interest Pfizer
BioPharma Dive via Yahoo Finance· 2 days agoThe venture firm will work with ProFound Therapeutics to “rapidly surface” protein drug candidates...
Bridgeway Capital Management LLC Boosts Stock Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 1 day agoBridgeway Capital Management LLC boosted its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 26.0% during the 4th quarter, according to its most recent 13F filing ...
Pfizer’s Phase III DMD gene therapy trial misses primary endpoint
Clinical Trials Arena via Yahoo Finance· 1 day agoPfizer has reported that its Phase III CIFFREO clinical trial of investigational mini-dystrophin...
Pfizer, Flagship to focus on obesity drugs under $100M collaboration - Boston Business Journal
The Business Journals· 2 days agoAlmost a year after Cambridge’s Flagship Pioneering and Pfizer Inc. announced a partnership to...
Pfizer's gene-therapy trial failure boosts Sarepta's stock
Morningstar· 1 day agoShares of Sarepta Therapeutics Inc. (SRPT) gained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a late-stage trial. Pfizer Inc. said ...
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 2 days agoPfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous...
Pfizer's Duchenne gene therapy fails in late-stage study
Reuters via AOL· 2 days agoThe therapy also did not show a significant difference compared to placebo in secondary goals of the...
Sarepta Therapeutics gains as Pfizer failure removes overhang By Investing.com
Investing.com· 1 day agoSarepta Therapeutics (NASDAQ:SRPT) stock rose over 3% Thursday after Pfizer (NYSE:PFE) announced...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock.
Motley Fool via Yahoo Finance· 6 days agoAnd investing in a safe, high-yielding dividend stock can make the most of your money. That's why a...